1stOncology™: Cancer Intelligence Service – Page 14432 – 1stOncology is recognized as a Top 10 Global Pharma Analytic Provider

Endocyte to Present at Deutsche Bank’s 43rd Annual Health Care Conference

On May 1, 2018 Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, reported that the company’s management team will present at Deutsche Bank’s 43rd Annual Health Care Conference being held at the Intercontinental Hotel Boston on Tuesday, May 8th at 1:35 p.m. EDT (Press release, Endocyte, MAY 1, 2018, View Source [SID1234525912]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

Schedule Your 30 min Free Demo!

A live audio webcast of the Company’s presentation can be accessed by visiting "Events & Presentations" under the Investors & News section of Endocyte’s website at www.endocyte.com. The webcast will be archived shortly after the live event, and a replay will be available on the Company’s website for 90 days following the conference.

Eagle Pharmaceuticals, Inc. to Discuss First Quarter 2018 Financial Results on May 10, 2018

On May 1, 2018 Eagle Pharmaceuticals, Inc. ("Eagle" or "the Company") (Nasdaq: EGRX) reported that the Company will release its 2018 first quarter financial results on Thursday, May 10, 2018, before the market opens (Press release, Eagle Pharmaceuticals, MAY 1, 2018, View Source [SID1234525911]).

Scott Tarriff, Chief Executive Officer, and Pete Meyers, Chief Financial Officer, will host a conference call to discuss the results as follows:

Date Thursday, May 10, 2018
Time 8:30 a.m. EDT
Toll free (U.S.) 877-876-9176
International 785-424-1667
Webcast (live and replay)
www.eagleus.com, under the "Investor Relations" section

A replay of the conference call will be available for one week after the call’s completion by dialing 800-839-3735 (US) or 402-220-2977 (International) and entering conference call ID EGRXQ118. The webcast will be archived for 30 days at the aforementioned URL.

Diplomat to Participate in 43rd Annual Deutsche Bank Health Care Conference

On May 1, 2018 Diplomat Pharmacy, Inc. (NYSE: DPLO), reported that executives will attend the 43rd Annual Deutsche Bank Health Care Conference in Boston (Press release, Diplomat Speciality Pharmacy, MAY 1, 2018, View Source [SID1234525910]).

Interim CEO Jeff Park, President Joel Saban, and Chief Financial Officer Atul Kavthekar are scheduled to present at 12:50 p.m. ET Wednesday, May 9.

A live audio-only webcast of the presentation and related materials will be available on the investor relations section of Diplomat’s website at ir.diplomat.is. The webcast and presentation materials will be online for 90 days.

CytomX Therapeutics to Announce First Quarter 2018 Financial Results

On May 1, 2018 CytomX Therapeutics, Inc. (Nasdaq:CTMX), a clinical-stage biopharmaceutical company developing investigational Probody therapeutics for the treatment of cancer, reported its first quarter 2018 financial results on Wednesday, May 9, 2018, after the NASDAQ market close (Press release, CytomX Therapeutics, MAY 1, 2018, View Source;p=RssLanding&cat=news&id=2346043 [SID1234525909]).

The company will not be conducting a conference call in connection with this financial results press release.

Aptose To Release First Quarter Ended March 31, 2018 Financial Results and Hold Conference Call on May 10, 2018

On May 1, 2018 Aptose Biosciences Inc. (NASDAQ:APTO) (TSX:APS), a clinical-stage biotechnology company developing first-in-class agents that target the dysregulated processes and signaling pathways of cancer cells and address unmet medical needs of patients with life-threatening hematologic cancers, reported that it will release its financial results for the quarter ended March 31, 2018, on Thursday, May 10, 2018 after the close of the market (Press release, Aptose Biosciences, MAY 1, 2018, View Source [SID1234525906]).

Conference Call & Webcast:
Thursday, May 10th @ 5:00pm Eastern Time
Toll-Free: (844) 882-7834
International: (574) 990-9707
Passcode: 2094769
Webcast: View Source

Replays available through May 17th, 2018
Toll-Free: (855) 859 2056
Replay Passcode: 2094769

The live conference call can also be accessed through a link on the Investor Relations section of Aptose’s website at ir.aptose.com. Please log onto the webcast at least 10 minutes prior to the start of the call to ensure time for any software downloads that may be required. An archived version of the webcast along with a transcript will be available on the company’s website for 30 days.

The press release, the financial statements and the management’s discussion and analysis for the quarter ended March 31, 2018 will be available on SEDAR at www.sedar.com and EDGAR at www.sec.gov/edgar.shtml